Primary tumors were excised between six and seven weeks after tumor inoculation and then, after two weeks of recovery, mice received five additional injections of 0.2 mg/kg doses of SLT-VEGF or saline on a twice weekly schedule. This evidence concerns the gene VEGFA and neoplasm.